H M Dhingra
Overview
Explore the profile of H M Dhingra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shin D, Dhingra H, Lee J, Fossella F, Murphy W, Hong W
Am J Clin Oncol
. 1992 Jun;
15(3):194-9.
PMID: 1317094
Forty-six patients with metastatic non-small-cell lung cancer (NSCLC) were treated with a combination of high-dose cisplatin, etoposide, and mitomycin. Thirty-four patients (74%) had a performance status of 1, and 39...
2.
Dhingra K, Talpaz M, Dhingra H, Ajani J, Rothberg J, Gutterman J
Invest New Drugs
. 1991 Feb;
9(1):37-9.
PMID: 1851142
Eighteen patients with advanced solid tumors were treated in a phase I study of cisplatinum in combination with recombinant alpha-2a interferon (Roferon-A, Hoffman-LaRoche, Inc, Nutley, NJ). Roferon-A was administered at...
3.
Dhingra H, Murphy W, Winn R, Raber M, Hong W
Invest New Drugs
. 1991 Feb;
9(1):69-72.
PMID: 1709153
No abstract available.
4.
Umsawasdi T, Dhingra H, Charnsangavej C, Luna M
Cancer
. 1991 Jan;
67(1):48-54.
PMID: 1898706
Long duration of responses to chemotherapy in patients with malignant pleural mesothelioma (MPM) is rare. The authors report a patient with inoperable MPM who achieved complete remission with combination chemotherapy...
5.
Holoye P, Glisson B, Lee J, Dhingra H, Murphy W, Umsawasdi T, et al.
Am J Clin Oncol
. 1990 Apr;
13(2):148-55.
PMID: 2156418
Fourteen patients with extensive disease small cell bronchogenic carcinoma (SCBC) received ifosfamide at 2,000 mg/m2/day for 5 consecutive days with simultaneous mesna and vincristine while 26 patients with extensive disease...
6.
Holoye P, McMurtrey M, Mountain C, Murphy W, Dhingra H, Umsawasdi T, et al.
J Clin Oncol
. 1990 Mar;
8(3):416-22.
PMID: 2307986
Twenty-six patients with a limited-disease presentation of small-cell bronchogenic carcinoma (SCBC) had surgery after achieving a partial remission with three cycles of chemotherapy. Persistent SCBC was found in 15 patients...
7.
Holoye P, Jeffries D, Dhingra H, Holmes F, Raber M, Engineer M, et al.
Cancer Chemother Pharmacol
. 1990 Jan;
26(2):147-50.
PMID: 2189591
The pharmacology, toxicity, and therapeutic effectiveness of etoposide (VP-16) given by the intrapleural route were examined in a phase I trial. Ten patients with malignant pleural effusion received 100, 150,...
8.
Umsawasdi T, Valdivieso M, Booser D, BARKLEY Jr H, Ewer M, Mackay B, et al.
Cancer
. 1989 Nov;
64(10):1995-2000.
PMID: 2553235
A prospective randomized study was done to determine the effect of different doxorubicin (Adriamycin [ADR], Adria Laboratories, Columbus, OH) administration (schedules every week versus every 3 weeks) on the productivity...
9.
Lee J, Murphy W, Glisson B, Dhingra H, Holoye P, Hong W
J Clin Oncol
. 1989 Jul;
7(7):916-22.
PMID: 2544685
Fourteen patients with brain metastases from previously untreated small-cell lung cancer (SCLC) were treated with three courses of systemic chemotherapy as an initial mode of treatment. Whole brain irradiation was...
10.
Holoye P, CARR D, Dhingra H, Glisson B, Lee J, Murphy W, et al.
Invest New Drugs
. 1988 Sep;
6(3):217-8.
PMID: 2847992
Fourteen evaluable patients with small cell bronchogenic carcinoma received tiazofurin, an inhibitor of inosine monophosphate dehydrogenase, that progressed after one combination chemotherapy. No objective remission was observed at the dosage...